Min Qing
Director, Oncology Precision Medicine & Diagnostic Johnson & Johnson
Seminars
Wednesday 12th November 2025
Advancing Patient Access to Treatment Options with Precision Dual-Sample Diagnostic Technology
12:30 pm
- Determining a fit-for-purpose assay strategy based on dual sample types or multi platforms
- How can pharma and diagnostic developers collaboratively balance assay complexity, analytical sensitivity, and clinical relevance?
- Designing strategies for clinical trial management and sample acquisition to address logistical challenges
